Literature DB >> 7752654

Calcium currents in diseased human cardiac cells.

H Ouadid1, B Albat, J Nargeot.   

Abstract

Isolated atrial or ventricular human cardiomyocytes were dissociated from the heart of patients undergoing either open heart surgery (CS) or cardiac transplantation (CT). L-type Ca currents were recorded on cardiomyocytes from CS or CT by whole-cell voltage clamp technique. Although the electrophysiologic properties of L-type Ca current were similar in atrial and ventricular myocytes from CS and CT patients, cells from CT had larger capacitance and lower current density. Whereas isoprenaline (Iso) induced an increase in the Ca current amplitude both in atrial and ventricular cells, a serotoninergic agonist (5-HT4) enhanced Ca current only in atrial cells. Although the affinity for Iso and 5-hydroxytryptamine (5-HT) was not modified between CS and CT (K0.5 = 0.1 microM), the amplitude of the response to both Iso and 5-HT were altered in CT. Some electrophysiologic and pharmacological properties of Ca current are altered in cardiomyopathic human hearts. These alterations correspond to (a) a reduction in the number of functional L-type Ca channels, and (b) a decreased response to both beta-adrenergic and serotoninergic agonists indicating that potentiation of Ca channel activity through the cyclic AMP pathway is altered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752654     DOI: 10.1097/00005344-199502000-00014

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  30 in total

1.  Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells.

Authors:  Henry M Colecraft; Badr Alseikhan; Shoji X Takahashi; Dipayan Chaudhuri; Scott Mittman; Vasan Yegnasubramanian; Rebecca S Alvania; David C Johns; Eduardo Marbán; David T Yue
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

Review 2.  Electrical and structural remodeling in left ventricular hypertrophy-a substrate for a decrease in QRS voltage?

Authors:  Ljuba Bacharova
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

Review 3.  Age-associated alterations in calcium current and its modulation in cardiac myocytes.

Authors:  Y Y Zhou; E G Lakatta; R P Xiao
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

Review 4.  Gene therapies for arrhythmias in heart failure.

Authors:  Fadi G Akar; Roger J Hajjar
Journal:  Pflugers Arch       Date:  2014-02-26       Impact factor: 3.657

5.  Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling.

Authors:  Jason D Bayer; Sanjiv M Narayan; Gautam G Lalani; Natalia A Trayanova
Journal:  Heart Rhythm       Date:  2010-04-08       Impact factor: 6.343

6.  Prolonged leptin treatment increases transient outward K⁺ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes.

Authors:  Nieves Gómez-Hurtado; María Fernández-Velasco; María Soledad Fernández-Alfonso; Lisardo Boscá; Carmen Delgado
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

Review 7.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

8.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

Review 9.  Electrophysiological remodeling in heart failure.

Authors:  Yanggan Wang; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2010-01-20       Impact factor: 5.000

10.  Cellular bases for human atrial fibrillation.

Authors:  Antony J Workman; Kathleen A Kane; Andrew C Rankin
Journal:  Heart Rhythm       Date:  2008-01-17       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.